Firma faCellitate, Autor bei PR-Web

faCellitate GmbH Wins 1st Place in Technology Category at the Mannheim Business Start-up Award (“Mannheimer Existenzgründerwettbewerb”) MEXI 2024

Posted on 2. October 20242. October 2024 by Firma faCellitate Posted in General Tagged award, biofloat, cancer, cell, coating, coatings, company, facellitate, mexi, new, research, roche, solutions, testing, with

faCellitate GmbH, a pioneering company in advanced cell culture technologies, has proudly secured 1st place in the prestigious Technology Category at the 2024 Mannheim Business Start-Up Award (MEXI), sponsored by Roche Diagnostics. This accolade, awarded during the 20th anniversary of […]

faCellitate Announces Results of a Study on 3D Cell Culture:

Posted on 7. March 20248. March 2024 by Firma faCellitate Posted in General Tagged biofloat, cells, coated plates, coatings, drug screening, facellitate, High throughput screening, lauschke, low adhesion plates, research, spheroid, tissue, ula

Publication in Biotechnology Journal A broadly designed comparative study conducted by researchers from Karolinska Institute in Stockholm has shown that BIOFLOAT™ 3D Cell Culture Plates have performance characteristics superior over all other 3D Cell Culture Plates investigated. Mannheim (Germany) and […]

faCellitate 2023: Cutting-edge Flat-Bottom microplates with Ultra-Low Adhesion Surface

Posted on 6. December 20236. December 2023 by Firma faCellitate Posted in General Tagged biofloat, cell, cells, coated microplate, coatings, drug screening, facellitate, flat bottom, High throughput screening, imaging, low adhesion plate, microplate, organoids, ula

faCellitate expands its product range with the launch of three new BIOFLOAT™ -coated flat-bottom microplates; a 96-well format, soon to be followed by 24- and 6-well plates. This innovative series is purposefully crafted as an addition to the BIOFLOAT 96-well […]

faCellitate appoints Christoph Petry, Ph.D. to become Managing Director and CEO

Posted on 30. November 20226. February 2023 by Firma faCellitate Posted in General Tagged 3D Cell Culture, biofloat, breast cancer, endopredict, facellitate, High throughput screening, labs, m2p, myriad, organoid, siemens, sividon, spheroid, therapy

faCellitate GmbH has appointed Dr. Christoph Petry, as Managing Director and CEO. Dr. Petry spun-out Sividon Diagnostics from Siemens Healthcare in 2010. Serving as Sividon’s CEO he oversaw the development of EndoPredict, a new standard to target breast cancer therapy […]

faCellitate Starts Marketing New 384-well Spheroid Microplate

Posted on 11. October 20226. February 2023 by Firma faCellitate Posted in General Tagged 384 ula, assay, cell, cells, centrifugation free, coatings, drug screening, facellitate, High throughput screening, hts, low adhesion plate, microplate, organoid, spheroid

faCellitate expands its BIOFLOAT™ coated microplate portfolio by a 384 well format specifically designed for spheroid culture The exceptional performance of the BIOFLOAT™ coating combined with the high density 384-format makes the new product solution particularly valuable for high-throughput spheroid […]

faCellitate, a BASF spin-off, closes a €3.7m seed round led by SARSTEDT and HTGF

Posted on 7. September 20226. February 2023 by Firma faCellitate Posted in General Tagged 3D Cell Culture, basf, cell therapy, Chemovator, facellitate, HTGF, LIFE SCIENCE, organoid, pharma, Sarstedt, spheroid, ULA microplate

Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting, ARVE Capital, ROI Verwaltungsgesellschaft and Chemovator. faCellitate has developed an intelligent and ultra-low attachment polymer surface coating platform. The first launched product thereof is targeting […]